NFE2L2 and non-small cell lung carcinoma: KEAP1 (Kelch-like ECH-associated protein 1) restrains NRF2; KEAP1 loss or mutation constitutively activates NRF2 programs, driving redox adaptation, metabolic rewiring, and therapy resistance in NSCLC.